🔬 Schistosomiasis Isn’t Silent—We Just Don’t Listen: The Diagnostic Gap No One Talks About

Schistosomiasis affects over 250 million people.

We have the drug.
We know the symptoms.
We even know where it spreads.

So why does the disease persist?

Because millions of infections are never even diagnosed.

---

📉 The Invisible Epidemic

Most people infected with schistosomiasis don’t even know they have it.

Early symptoms are mild or dismissed:
→ Itchy skin
→ Mild abdominal pain
→ Fatigue

In rural or under-resourced areas, these are just facts of life.

Without lab tests, no one connects the dots.

By the time real symptoms appear—organ damage, blood in urine, chronic pain—it’s already too late.

---

🧪 Diagnostics Should Be Simple. They’re Not.

Here’s the catch:
Diagnosing schistosomiasis isn’t that hard.
But it requires tools, trained personnel, and lab access.

And most of the affected regions have none of the above.

Current methods rely on:
→ Microscopy (examining urine/stool for parasite eggs)
→ Rapid antigen tests (still not widely deployed)
→ Serological tests (require equipment and expertise)

In too many places, the reality is: no tests = no treatment.

---

💊 The Drug Exists—But Access Doesn’t

Praziquantel, the drug used to treat schistosomiasis, costs less than a dollar.

It works in one dose.
It’s been around for decades.
But even with this miracle pill, treatment coverage is shockingly low.

Why?

→ Medication isn’t stocked at local clinics
→ Health workers aren’t trained to recognize or treat it
→ Treatment campaigns are sporadic, underfunded, or donor-dependent
→ Adults—especially women—are often excluded from mass drug administration (MDA) programs

We’re not failing because the disease is complicated.
We’re failing because the systems are broken.

---

🧭 What Needs to Happen

If we want to end schistosomiasis, we need to diagnose it before it destroys lives—and treat it without delay.

That means:

→ Deploying rapid, low-cost diagnostic tools to primary care centers
→ Training frontline health workers in endemic regions
→ Ensuring a consistent supply chain of praziquantel
→ Expanding treatment campaigns to include everyone, not just schoolchildren

Diagnostics are not optional. They are the foundation of disease control.

Because what we don’t detect, we can’t treat.
And what we don’t treat, spreads.

---

At Empower Research Foundation, we are:

✔️ Supporting development and deployment of rapid tests
✔️ Advocating for better drug access in rural communities
✔️ Elevating diagnostics as a key pillar in NTD elimination strategy

---

Final Thought:

You can’t fix what you don’t see.

And right now, the world is looking away.

Schistosomiasis is still winning because we’re still ignoring the basics: diagnose, treat, prevent.

Let’s close the gap—before more lives are lost to a disease we already know how to cure.